Boston Scientific Pre-Tax Profit Margin 2012-2026 | BSX
Current and historical pre-tax profit margin for Boston Scientific (BSX) from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Boston Scientific pre-tax profit margin for the three months ending June 30, 2026 was .
| Boston Scientific Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-06-30 | $21.00B | $3.86B | 18.39% |
| 2026-03-31 | $20.61B | $3.74B | 18.15% |
| 2025-12-31 | $20.07B | $3.39B | 16.86% |
| 2025-09-30 | $19.35B | $3.27B | 16.90% |
| 2025-06-30 | $18.50B | $3.00B | 16.22% |
| 2025-03-31 | $17.55B | $2.48B | 14.12% |
| 2024-12-31 | $16.75B | $2.28B | 13.63% |
| 2024-09-30 | $15.91B | $2.20B | 13.84% |
| 2024-06-30 | $15.23B | $2.14B | 14.07% |
| 2024-03-31 | $14.71B | $2.15B | 14.61% |
| 2023-12-31 | $14.24B | $1.99B | 13.94% |
| 2023-09-30 | $13.76B | $1.88B | 13.63% |
| 2023-06-30 | $13.40B | $1.51B | 11.27% |
| 2023-03-31 | $13.05B | $1.43B | 10.95% |
| 2022-12-31 | $12.68B | $1.14B | 9.00% |
| 2022-09-30 | $12.57B | $0.87B | 6.88% |
| 2022-06-30 | $12.33B | $1.10B | 8.95% |
| 2022-03-31 | $12.16B | $0.91B | 7.46% |
| 2021-12-31 | $11.89B | $1.08B | 9.05% |
| 2021-09-30 | $11.47B | $1.26B | 11.02% |
| 2021-06-30 | $11.20B | $0.55B | 4.95% |
| 2021-03-31 | $10.12B | $0.22B | 2.21% |
| 2020-12-31 | $9.91B | $-0.08B | -0.80% |
| 2020-09-30 | $10.11B | $-0.39B | -3.88% |
| 2020-06-30 | $10.16B | $-0.07B | -0.73% |
| 2020-03-31 | $10.79B | $0.25B | 2.34% |
| 2019-12-31 | $10.74B | $0.69B | 6.40% |
| 2019-09-30 | $10.39B | $0.99B | 9.52% |
| 2019-06-30 | $10.08B | $1.35B | 13.44% |
| 2019-03-31 | $9.94B | $1.56B | 15.66% |
| 2018-12-31 | $9.82B | $1.42B | 14.48% |
| 2018-09-30 | $9.67B | $1.35B | 14.00% |
| 2018-06-30 | $9.50B | $1.21B | 12.71% |
| 2018-03-31 | $9.27B | $0.95B | 10.26% |
| 2017-12-31 | $9.05B | $0.93B | 10.31% |
| 2017-09-30 | $8.83B | $0.79B | 8.99% |
| 2017-06-30 | $8.71B | $0.74B | 8.52% |
| 2017-03-31 | $8.58B | $0.25B | 2.96% |
| 2016-12-31 | $8.39B | $0.18B | 2.11% |
| 2016-09-30 | $8.17B | $-0.25B | -3.05% |
| 2016-06-30 | $7.96B | $-0.87B | -10.97% |
| 2016-03-31 | $7.67B | $-0.37B | -4.84% |
| 2015-12-31 | $7.48B | $-0.65B | -8.69% |
| 2015-09-30 | $7.39B | $-0.87B | -11.74% |
| 2015-06-30 | $7.34B | $-0.50B | -6.77% |
| 2015-03-31 | $7.37B | $-0.71B | -9.57% |
| 2014-12-31 | $7.38B | $-0.51B | -6.90% |
| 2014-09-30 | $7.33B | $0.10B | 1.42% |
| 2014-06-30 | $7.22B | $0.06B | 0.84% |
| 2014-03-31 | $7.16B | $0.32B | 4.43% |
| 2013-12-31 | $7.14B | $-0.22B | -3.12% |
| 2013-09-30 | $7.13B | $-0.23B | -3.24% |
| 2013-06-30 | $7.13B | $-0.85B | -11.99% |
| 2013-03-31 | $7.14B | $-4.62B | -64.73% |
| 2012-12-31 | $7.25B | $-4.11B | -56.66% |
| 2012-09-30 | $7.28B | $-4.06B | -55.76% |
| 2012-06-30 | $7.42B | $-3.28B | -44.28% |
| 2012-03-31 | $7.56B | $0.49B | 6.51% |
| 2011-12-31 | $7.62B | $0.64B | 8.42% |
| 2011-09-30 | $7.78B | $0.77B | 9.93% |
| 2011-06-30 | $7.82B | $0.82B | 10.54% |
| 2011-03-31 | $7.77B | $0.79B | 10.10% |
| 2010-12-31 | $7.81B | $-1.06B | -13.62% |
| 2010-09-30 | $7.88B | $-2.64B | -33.49% |
| 2010-06-30 | $7.99B | $-2.85B | -35.62% |
| 2010-03-31 | $8.14B | $-2.79B | -34.23% |
| 2009-12-31 | $8.19B | $-1.31B | -15.97% |
| 2009-09-30 | $8.11B | $-2.49B | -30.65% |
| 2009-06-30 | $8.06B | $-2.51B | -31.13% |
| 2009-03-31 | $8.01B | $-2.59B | -32.32% |
| 2008-12-31 | $8.05B | $-2.03B | -25.23% |
| 2008-09-30 | $8.20B | $-0.10B | -1.23% |
| 2008-06-30 | $8.27B | $-0.29B | -3.53% |
| 2008-03-31 | $8.32B | $-0.27B | -3.20% |
| 2007-12-31 | $8.36B | $-0.57B | -6.81% |
| 2007-09-30 | $8.27B | $0.20B | 2.36% |
| 2007-06-30 | $8.25B | $0.51B | 6.12% |
| 2007-03-31 | $8.29B | $-3.81B | -45.94% |
| 2006-12-31 | $7.82B | $-3.54B | -45.20% |
| 2006-09-30 | $7.30B | $-3.27B | -44.76% |
| 2006-06-30 | $6.78B | $-3.67B | -54.11% |
| 2006-03-31 | $6.29B | $0.83B | 13.17% |
| 2005-12-31 | $6.28B | $0.89B | 14.18% |
| 2005-09-30 | $6.34B | $0.91B | 14.38% |
| 2005-06-30 | $6.31B | $1.61B | 25.53% |
| 2005-03-31 | $6.16B | $1.73B | 28.15% |
| 2004-12-31 | $5.62B | $1.49B | 26.56% |
| 2004-09-30 | $4.96B | $1.22B | 24.56% |
| 2004-06-30 | $4.36B | $1.03B | 23.62% |
| 2004-03-31 | $3.75B | $0.76B | 20.21% |
| 2003-12-31 | $3.48B | $0.64B | 18.50% |
| 2003-09-30 | $3.35B | $0.60B | 17.96% |
| 2003-06-30 | $3.20B | $0.68B | 21.24% |
| 2003-03-31 | $3.05B | $0.57B | 18.75% |
| 2002-12-31 | $2.92B | $0.55B | 18.81% |
| 2002-09-30 | $2.78B | $0.50B | 18.04% |
| 2002-06-30 | $2.73B | $0.35B | 12.97% |
| 2002-03-31 | $2.69B | $0.13B | 4.97% |
| 2001-12-31 | $2.67B | $0.04B | 1.65% |
| 2001-09-30 | $2.63B | $0.03B | 1.14% |
| 2001-06-30 | $2.62B | $0.06B | 2.37% |
| 2001-03-31 | $2.64B | $0.40B | 15.08% |
| 2000-12-31 | $2.66B | $0.53B | 19.78% |
| 2000-09-30 | $2.74B | $0.61B | 22.13% |
| 2000-06-30 | $2.78B | $0.57B | 20.56% |
| 2000-03-31 | $2.81B | $0.57B | 20.16% |
| 1999-12-31 | $2.84B | $0.56B | 19.77% |
| 1999-09-30 | $2.84B | $0.55B | 19.32% |
| 1999-06-30 | $2.73B | $-0.18B | -6.64% |
| 1999-03-31 | $2.49B | $-0.22B | -8.92% |
| 1998-12-31 | $2.23B | $-0.28B | -12.32% |
| 1998-09-30 | $2.00B | $-0.38B | -18.89% |
| 1998-06-30 | $1.88B | $0.40B | 20.98% |
| 1998-03-31 | $1.86B | $0.25B | 13.35% |
| 1997-12-31 | $1.83B | $0.26B | 14.09% |
| 1997-09-30 | $1.76B | $0.33B | 18.47% |
| 1997-06-30 | $1.67B | $0.30B | 18.06% |
| 1997-03-31 | $1.57B | $0.37B | 23.82% |
| 1996-12-31 | $1.46B | $0.30B | 20.38% |
| 1996-09-30 | $1.35B | $0.18B | 13.09% |
| 1996-06-30 | $1.26B | $0.15B | 11.66% |
| 1996-03-31 | $1.13B | $0.17B | 15.12% |
| 1995-12-31 | $1.03B | $0.09B | 8.39% |
| 1995-09-30 | $0.85B | $0.13B | 15.45% |
| 1995-06-30 | $0.68B | $0.09B | 13.29% |
| 1995-03-31 | $0.63B | $0.05B | 7.68% |
| 1994-12-31 | $0.58B | $0.13B | 22.13% |
| 1994-09-30 | $0.56B | $0.12B | 21.89% |
| 1994-06-30 | $0.55B | $0.12B | 21.61% |
| 1994-03-31 | $0.47B | $0.12B | 24.73% |
| 1993-12-31 | $0.38B | $0.11B | 28.95% |
| 1993-09-30 | $0.36B | $0.16B | 44.63% |
| 1993-06-30 | $0.35B | $0.16B | 45.85% |
| 1993-03-31 | $0.33B | $0.15B | 46.53% |
| 1992-12-31 | $0.32B | $0.20B | 64.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $63.114B | $20.074B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.897B | 19.43 |
| Medtronic (MDT) | Ireland | $118.666B | 16.22 |
| Stryker (SYK) | United States | $107.450B | 20.08 |
| EssilorLuxottica (ESLOY) | France | $75.078B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.379B | 0.00 |
| Agilent Technologies (A) | United States | $44.077B | 25.80 |
| Medline (MDLN) | United States | $42.228B | 0.00 |
| ResMed (RMD) | United States | $32.950B | 20.45 |
| GE HealthCare Technologies (GEHC) | United States | $29.109B | 13.92 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $21.654B | 20.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.977B | 11.11 |
| Baxter (BAX) | United States | $11.901B | 11.23 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.666B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.225B | 41.21 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.817B | 24.11 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.579B | 20.24 |
| BillionToOne (BLLN) | United States | $5.222B | 158.10 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.122B | 0.00 |
| Haemonetics (HAE) | United States | $4.895B | 21.48 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.822B | 22.82 |
| Envista Holdings (NVST) | United States | $3.805B | 16.12 |
| AtriCure (ATRC) | United States | $3.007B | 257.04 |
| Neogen (NEOG) | United States | $2.798B | 49.35 |
| Curaleaf Holdings (CURLF) | United States | $2.396B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.288B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.243B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.201B | 10.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.888B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.871B | 5.39 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 29.22 |
| BioLife Solutions (BLFS) | United States | $1.803B | 230.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.436B | 15.31 |
| Phibro Animal Health (PAHC) | United States | $1.399B | 10.73 |
| Omeros (OMER) | United States | $1.336B | 6.76 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.107B | 0.00 |
| CeriBell (CBLL) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.836B | 11.63 |
| AdaptHealth (AHCO) | United States | $0.785B | 16.46 |
| VAREX IMAGING (VREX) | United States | $0.781B | 17.17 |
| QuidelOrtho (QDEL) | United States | $0.761B | 8.21 |
| Glass House Brands (GLAS) | United States | $0.749B | 0.00 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.548B | 0.00 |
| Brainsway (BWAY) | Israel | $0.544B | 30.75 |
| Vireo Growth (VREOF) | United States | $0.540B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.537B | 0.00 |
| Cerus (CERS) | United States | $0.536B | 0.00 |
| Evolus (EOLS) | United States | $0.529B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.446B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.350B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.86 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.302B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 13.28 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.62 |
| High Tide (HITI) | Canada | $0.236B | 53.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.191B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.151B | 0.00 |
| Quanterix (QTRX) | United States | $0.148B | 0.00 |
| Apyx Medical (APYX) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.091B | 124.75 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.77 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.079B | 4.48 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 3.97 |
| Nephros (NEPH) | United States | $0.046B | 38.46 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.21 |
| United-Guardian (UG) | United States | $0.033B | 13.39 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |